2022
DOI: 10.1128/spectrum.02729-21
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 Lineage Tracking, and Evolving Trends Seen during Three Consecutive Peaks of Infection in Delhi, India: a Clinico-Genomic Study

Abstract: Genome surveillance of the Delhi data provides a more detailed picture of diverse circulating lineages. The added value that the current study provides by clinical details of the patients is of importance.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
2
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 27 publications
1
2
1
Order By: Relevance
“…In the first two peaks median CT values were found to be more than 20. This is in contrast to what has been reported by Gautam et al 2022, where the median CT in the first two peaks were found to be 15 (Gautam et al, 2022).…”
Section: Discussioncontrasting
confidence: 99%
See 2 more Smart Citations
“…In the first two peaks median CT values were found to be more than 20. This is in contrast to what has been reported by Gautam et al 2022, where the median CT in the first two peaks were found to be 15 (Gautam et al, 2022).…”
Section: Discussioncontrasting
confidence: 99%
“…During the first peak B.1.560 lineage was found to be more common which was replaced by B.1.617.2 lineage during second peak. This was similar to a study in Delhi (Gautam et al, 2022). The beginning of third peak had B.1.617.2 lineage which slowly less detected with an increase in BA.2 and BA.1.1.7 lineage.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…The propagated outbreak of COVID-19 and global vaccination drive have exerted an immense immunological selection pressure on SARS CoV-2. Therefore, since its first case in December 2019, five variants of concern (VOC) have evolved -Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2) and Omicron (B.1.1.529) (2,10). Within a span of two years Delta and Omicron variants have become dominant VOCs due to their increased transmissibility and decreased neutralization with vaccine or naturally acquired antibodies (2,(11)(12)(13)(14).…”
Section: Introductionmentioning
confidence: 99%